CytoMed Therapeutics Limited - Ordinary Shares (GDTC)

CytoMed Therapeutics Limited is a biotechnology company dedicated to the development of innovative therapies that harness the power of the immune system to treat various diseases, including cancer

The company focuses on creating advanced cellular and gene therapies designed to enhance the body’s natural defenses against harmful cells. Through rigorous research and cutting-edge technology, CytoMed aims to bring transformative treatment options to patients, addressing unmet medical needs and improving outcomes in therapeutic areas where traditional methods may fall short. Their commitment to science and patient care positions them as a forward-thinking entity in the biopharmaceutical landscape.